VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3131
ETF rank
โ‚น1.50 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น2,028
Share price
0.32%
Change (1 day)
23.88%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of December 2025: 0.35%